Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Agus
David Agus, Beverly Hills, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080318230 | GENE EXPRESSION MARKERS FOR RESPONSE TO EGFR INHIBITOR DRUGS - The present invention concerns prognostic markers associated with cancer. In particular, the invention concerns prognostic methods based on the molecular characterization of gene expression in paraffin-embedded, fixed samples of cancer tissue, which allow a physician to predict whether a patient is likely to respond well to treatment with an EGFR inhibitor. | 12-25-2008 |
David B. Agus, Beverly Hills, GA US
| Patent application number | Description | Published |
|---|---|---|
| 20090008546 | Bi-Directional System For Mass Spectrometry - The present invention relates to a system and method for mass spectrometry ( | 01-08-2009 |
| 20110064737 | ErbB ANTAGONISTS FOR PAIN THERAPY - The present application describes the use of ErbB antagonist, especially ErbB2 antibodies such as rhuMAb 2C4, for treating pain. | 03-17-2011 |
David B. Agus, Los Angeles, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100297152 | METHODS OF DIAGNOSIS OF PROSTATE CANCER, COMPOSITIONS AND METHODS OF SCREENING FOR MODULATORS OF PROSTATE CANCER - Described herein are genes whose expression are up-regulated or down-regulated in prostate cancer. Also described are such genes whose expression is further up-regulated or down-regulated in drug-resistant prostate cancer cells. Related methods and compositions that can be used for diagnosis and treatment of prostate cancer are disclosed. Also described herein are methods that can be used to identify modulators of prostate cancer. | 11-25-2010 |
David B. Agus, Beverly Hill, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100055697 | POSITIVE SELECTION OF SERUM PROTEINS FOR PROTEOMIC ANALYSIS - This invention relates to methods and kits for positive selection of species of interest based on peptide/protein sequence from a biological sample. The species of interest may be proteins and/or peptides of interest which may be placed through a mass spectrometer to obtain a blood peptide/protein signature. The blood peptide/protein signature may be used in proteomic analysis. The techniques include but are not limited to the use of collectors comprising nucleic acid molecules to extract a composition that has a lower concentration of a high abundance species of interest from a sample. This limits the level of influence that any collectors species may have on the results of a mass spectra. | 03-04-2010 |
Mariani Agus, Duvall, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20090222427 | Online Tracking of Life-Limited Parts - This application describes tools for online tracking of life-limited parts. These tools may support methods that include receiving queries, and searching databases in response to the queries. These methods may integrate results of the searches into reports that provide comprehensive histories of life-limited parts for installation within vehicles, and may report these integrated results. To build these databases, other methods may receive information relating to the life-limited parts from a variety of sources, load the information into suitable databases, and integrate this information as provided by the various sources. Other methods may also evaluate whether the parts have any permitted life remaining. These tools may also provide databases that store serial numbers associated with the parts, store physical locations of the parts at various times, indicate who owned the parts at different times, and include remaining life records that indicate any permitted life remaining for the parts. | 09-03-2009 |
Michael Agus, Boston, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090012376 | Continuous Analyte Monitor and Method of Using Same - The use of an analyte-monitoring device for continuously monitoring analytes within a bodily fluid bypass flow path. A method of monitoring analytes in a patient by continuously monitoring analytes present in a bodily fluid of that patient within the bodily fluid bypass flow path is provided. | 01-08-2009 |